Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 11-May-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Arformoterol Tartrate Inhalation Solution, 15 mcg (base)/2 mL Unit-dose Vial
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 11-May-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Arformoterol Tartrate Inhalation Solution, 15 mcg (base)/2 mL Unit-dose Vial